Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome

Monika Meena, Christopher Destephano, William J. Watson, Brian C. Brost

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Shrinking lung syndrome is characterized by pulmonary compromise secondary to unilateral or bilateral paralysis of the diaphragm. Case: Shrinking lung syndrome was diagnosed in a patient with antiphospholipid syndrome after a cesarean delivery at 28 4/7 weeks of gestation. Signs and symptoms included unexplained right-side chest pain, dyspnea, tachypnea, and absent breath sounds at the right base of the lungs. After initiation of corticosteroids, her symptoms resolved. Conclusion: Although seen in association with systemic lupus erythematosus, shrinking lung syndrome has not been described with antiphospholipid syndrome or during pregnancy. Diagnosis and awareness are important because treatment with moderate- to high-dose corticosteroids appears to improve the clinical outcome.

Original languageEnglish (US)
Pages (from-to)506-508
Number of pages3
JournalObstetrics and Gynecology
Volume117
Issue number2 PART 2
DOIs
StatePublished - Feb 1 2011

Fingerprint

Antiphospholipid Syndrome
Pregnancy
Lung
Adrenal Cortex Hormones
Tachypnea
Diaphragm
Chest Pain
Paralysis
Systemic Lupus Erythematosus
Dyspnea
Signs and Symptoms

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome. / Meena, Monika; Destephano, Christopher; Watson, William J.; Brost, Brian C.

In: Obstetrics and Gynecology, Vol. 117, No. 2 PART 2, 01.02.2011, p. 506-508.

Research output: Contribution to journalArticle

Meena, Monika ; Destephano, Christopher ; Watson, William J. ; Brost, Brian C. / Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome. In: Obstetrics and Gynecology. 2011 ; Vol. 117, No. 2 PART 2. pp. 506-508.
@article{c9025b98419843ceb97fad41b6eb6b56,
title = "Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome",
abstract = "Background: Shrinking lung syndrome is characterized by pulmonary compromise secondary to unilateral or bilateral paralysis of the diaphragm. Case: Shrinking lung syndrome was diagnosed in a patient with antiphospholipid syndrome after a cesarean delivery at 28 4/7 weeks of gestation. Signs and symptoms included unexplained right-side chest pain, dyspnea, tachypnea, and absent breath sounds at the right base of the lungs. After initiation of corticosteroids, her symptoms resolved. Conclusion: Although seen in association with systemic lupus erythematosus, shrinking lung syndrome has not been described with antiphospholipid syndrome or during pregnancy. Diagnosis and awareness are important because treatment with moderate- to high-dose corticosteroids appears to improve the clinical outcome.",
author = "Monika Meena and Christopher Destephano and Watson, {William J.} and Brost, {Brian C.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1097/AOG.0b013e318206c254",
language = "English (US)",
volume = "117",
pages = "506--508",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "2 PART 2",

}

TY - JOUR

T1 - Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome

AU - Meena, Monika

AU - Destephano, Christopher

AU - Watson, William J.

AU - Brost, Brian C.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Background: Shrinking lung syndrome is characterized by pulmonary compromise secondary to unilateral or bilateral paralysis of the diaphragm. Case: Shrinking lung syndrome was diagnosed in a patient with antiphospholipid syndrome after a cesarean delivery at 28 4/7 weeks of gestation. Signs and symptoms included unexplained right-side chest pain, dyspnea, tachypnea, and absent breath sounds at the right base of the lungs. After initiation of corticosteroids, her symptoms resolved. Conclusion: Although seen in association with systemic lupus erythematosus, shrinking lung syndrome has not been described with antiphospholipid syndrome or during pregnancy. Diagnosis and awareness are important because treatment with moderate- to high-dose corticosteroids appears to improve the clinical outcome.

AB - Background: Shrinking lung syndrome is characterized by pulmonary compromise secondary to unilateral or bilateral paralysis of the diaphragm. Case: Shrinking lung syndrome was diagnosed in a patient with antiphospholipid syndrome after a cesarean delivery at 28 4/7 weeks of gestation. Signs and symptoms included unexplained right-side chest pain, dyspnea, tachypnea, and absent breath sounds at the right base of the lungs. After initiation of corticosteroids, her symptoms resolved. Conclusion: Although seen in association with systemic lupus erythematosus, shrinking lung syndrome has not been described with antiphospholipid syndrome or during pregnancy. Diagnosis and awareness are important because treatment with moderate- to high-dose corticosteroids appears to improve the clinical outcome.

UR - http://www.scopus.com/inward/record.url?scp=79251580235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251580235&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e318206c254

DO - 10.1097/AOG.0b013e318206c254

M3 - Article

C2 - 21252806

AN - SCOPUS:79251580235

VL - 117

SP - 506

EP - 508

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 2 PART 2

ER -